Protective Effects of a Novel Nonglucocorticoid 21-Aminosteroid (U74006F) During Traumatic Shock in Rats

Publisher Website
Google Scholar
Abstract
The purpose of this study was to investigate the effect of the nonglucocorticoid steroid U74006F in the pathogenesis of a murine traumatic shock model. Pentobarbital-anesthetized (40 mg/kg) rats were subjected to Noble-Collip drum trauma and developed a lethal shock state characterized by a decreased mean arterial blood pressure (MABP) to 67 ± 2 mm Hg and survival time (1.5 ± 0.2 h). In contrast, sham trauma rats exhibited a MABP of 122 ± 4 mm Hg at 5 h postanesthesia. Administration of U74006F at doses of 22.5 mg/kg at 15 to 20 min following trauma significantly maintained a higher MABP and prolonged survival compared to those trauma rats receiving only the vehicle for U74006F (0.002 N HCl). U74006F at 15 and 22.5 mg/kg prolonged survival time to 2.6 ± 0.3 (p < 0.05) and 3.1 ± 0.6 h (p < 0.02), respectively. U74006F also significantly attenuated the plasma accumulation of cathepsin D (p < 0.02 to p < 0.01) and free amino-nitrogen compounds (p < 0.01) compared to the rats receiving only vehicle. Additionally, U74006F at 15 and 22.5 mg/kg blunted the production of the cardiotoxic peptide, myocardial depressant factor (MDF) (p < 0.01 to p < 0.001). Moreover, U74006F is a steroid without significant glucocorticoid or mineralocorticoid activity. These results suggest that U74006F may be useful as a therapeutic agent in traumatic shock.